Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Yan Topilsky Added: 3 years ago
In contrast to aortic or mitral diseases, there has been far less discussion on indications for tricuspid valve repair or replacement. Despite the fact that tricuspid regurgitation (TR) can result in significant symptoms, it remains undertreated. Patients are rarely referred for isolated surgical repair, or replacement, and most surgeries are performed in the context of other planned cardiac… View more
Author(s): Jose Luis Zamorano , Rebecca T Hahn , Patrizio Lancellotti , et al Added: 2 years ago
In this on-demand programme,a world-renowned faculty led byProgramme ChairProf José Luis Zamorano (University Complutense, Spain) and Scientific Director Dr Rebecca THahn(New York-Presbyterian / Columbia University Medical Center, US), explore tips, tricks and expert insight to optimise echocardiographic image acquisition strategies to support earlier diagnosis and improved patient outcomes. … View more
Author(s): Paul Sorajja Added: 11 months ago
EuroPCR 23 - Dr Paul Sorajja (Abbott Northwestern Hospital, US) joined us to discuss the TRILUMINATE Pivotal study (NCT03904147). The aim of this trial is to evaluate the safety and effectiveness of the tricuspid transcatheter edge-to-edge repair (TriClip, Abbott) in improving clinical outcomes for symptomatic patients with severe tricuspid regurgitation (TR) who have an intermediate or higher… View more
Author(s): Antonio Popolo Rubbio Added: 1 year ago
In this short video, Dr Antonio Popolo Rubbio (IRCCS Policlinico San Donato, IT) shares the key findings from a study that assessed the use of the MitraClip in patients with atrial functional mitral regurgitation. Discussion Points 1. Study Background 2. Mitraclip Procedure 3. Study Design & the Patient Selection Criteria 4. Key Findings 5. Which Patients Would Benefit the Most from this… View more
Author(s): Ralph Stephan von Bardeleben , Paul Sorajja , Gilbert Tang , et al Added: 10 months ago
Severe tricuspid regurgitation is an urgent global healthcare challenge, affecting over 70 million individuals worldwide. The associated adverse outcomes and burdensome symptoms demand effective solutions. While surgical intervention and medical therapy have been the traditional approaches, a new era has dawned with transcatheter repair emerging as a game-changing option. In this on-demand… View more
Author(s): Eduardo A Arias , Amit Bhan , Zhan Lim , et al Added: 3 years ago
During the past decade, transcatheter aortic valve implantation (TAVI) has revolutionised the interventional treatment of aortic stenosis (AS).1 It has rapidly evolved from a treatment used on a compassionate basis for inoperable patients to being the standard of care in high-risk AS.2,3 In that cohort it has proven to be non-inferior to surgical aortic valve replacement (SAVR) in terms of… View more